1. Home
  2. TLYS vs LITS Comparison

TLYS vs LITS Comparison

Compare TLYS & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$1.69

Market Cap

51.2M

ML Signal

HOLD

LITS

Lite Strategy Inc.

N/A

Current Price

$1.42

Market Cap

54.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TLYS
LITS
Founded
1982
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.2M
54.1M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
TLYS
LITS
Price
$1.69
$1.42
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$2.25
N/A
AVG Volume (30 Days)
83.1K
781.2K
Earning Date
12-03-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$545,742,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$1.30
52 Week High
$4.60
$9.00

Technical Indicators

Market Signals
Indicator
TLYS
LITS
Relative Strength Index (RSI) 45.68 N/A
Support Level $1.58 N/A
Resistance Level $1.86 N/A
Average True Range (ATR) 0.14 0.00
MACD -0.04 0.00
Stochastic Oscillator 22.66 0.00

Price Performance

Historical Comparison
TLYS
LITS

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: